MoneyWorks4Me

The Revenue for the quarter ended  March 2022 of Rs. 521.36 millions grew by 21.71 % from Rs. 428.36 millions.A big loss of -99.53% reported for the quarter ended March 2022 to Rs. 0.24  millions from Rs. 50.99 millions.Operating profit for the quarter ended March 2022 decreased to 9.02 millions as compared to 77.76 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 521.36 428.36 21.71 2260.97 1879.46 20.30 2260.97 1879.46 20.30
Other Income 2.76 26.61 -89.63 33.36 43.93 -24.06 33.36 43.93 -24.06
PBIDT 9.02 77.76 -88.40 291.31 234.72 24.11 291.31 234.72 24.11
Interest 0.58 1.30 -55.38 2.85 5.14 -44.55 2.85 5.14 -44.55
PBDT 8.44 76.46 -88.96 288.46 229.58 25.65 288.46 229.58 25.65
Depreciation 6.45 2.63 145.25 15.26 10.86 40.52 15.26 10.86 40.52
PBT 1.99 73.83 -97.30 273.20 218.72 24.91 273.20 218.72 24.91
TAX 1.75 22.84 -92.34 77.32 48.14 60.61 77.32 48.14 60.61
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.24 50.99 -99.53 195.88 170.58 14.83 195.88 170.58 14.83
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 1.73 18.15 -90.47 12.88 12.49 3.17 12.88 12.49 3.17
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..